Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
vgLMZ2CK5mhhbrhY
Listen
